Kai Wang

机构：Shandong University, Zunyi Medical University, Nanfang Hospital, Qilu Hospital of Shandong University, Southern Medical University · ORCID：0000-0001-5814-817X

发表论文 31 篇 · 总被引 443 次 · h-index 11

代表论文

• High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients (2021 · npj Precision Oncology · 被引 94)
• ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway (2021 · Cell Death and Disease · 被引 54)
• Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1/M2-macrophage infusion on liver recovery after hepatectomy (2021 · Cell Death and Disease · 被引 41)
• Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress (2020 · Cell Death and Disease · 被引 41)
• CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease (2023 · American Journal of Physiology-Cell Physiology · 被引 34)
• Generation of sphingosine-1-phosphate by sphingosine kinase 1 protects nonalcoholic fatty liver from ischemia/reperfusion injury through alleviating reactive oxygen species production in hepatocytes (2020 · Free Radical Biology and Medicine · 被引 18)